VITASPRING BIOMEDICAL CO., LTD. Deferred Federal Income Tax Expense (Benefit)
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Deferred Federal Income Tax Expense (Benefit) of $0 for the 12-month period ending 2024-01-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-12
- VITASPRING BIOMEDICAL CO., LTD. deferred federal income tax expense (benefit) for fiscal 2024 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. deferred federal income tax expense (benefit) for fiscal 2023 was -$6.18K, a 200.00% decline from fiscal 2022.
- VITASPRING BIOMEDICAL CO., LTD. deferred federal income tax expense (benefit) for fiscal 2022 was $6.18K, a 93.42% decline from fiscal 2021.
- VITASPRING BIOMEDICAL CO., LTD. deferred federal income tax expense (benefit) for fiscal 2021 was $93.93K.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2024-01-31 | $0.00 10-K · filed 2026-03-12 |
| 2023-01-31 | -$6.18K 10-K · filed 2026-03-12 |
| 2022-01-31 | $6.18K 10-K · filed 2025-12-01 |
| 2021-01-31 | $93.93K 10-K · filed 2022-05-03 |